Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$2.59 - $3.36 $5,762 - $7,476
-2,225 Reduced 8.73%
23,252 $62,000
Q2 2021

Aug 06, 2021

BUY
$3.11 - $4.87 $15,260 - $23,897
4,907 Added 23.86%
25,477 $88,000
Q1 2021

May 14, 2021

SELL
$3.66 - $7.67 $20,488 - $42,936
-5,598 Reduced 21.39%
20,570 $84,000
Q4 2020

Feb 12, 2021

BUY
$3.03 - $5.51 $79,289 - $144,185
26,168 New
26,168 $116,000

Others Institutions Holding GNPX

About Genprex, Inc.


  • Ticker GNPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,300
  • Market Cap $76.8M
  • Description
  • Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...
More about GNPX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.